Chr. Hansen wins emerging science award for innovative microbe screening platform
da Mosbech Smith, PhD student in Chr. Hansen Health & Nutrition Discovery, presented results from a project where the platform was used to identify yeasts capable of modulating human inflammatory responses.
At this year’s Probiota congress in Amsterdam, a panel of leading industry experts selected Chr. Hansen as one of three emerging science winners, for their in vitro microbe screening platform. The platform enables identification of microbes capable of modifying the function of human immune cells.
These capabilities are expected to exert a health benefit in conditions of excessive inflammation and the platform is currently being expanded to be used in Chr. Hansen’s large bacteria screening programs.
Important understanding in developing probiotic products
Benedicte Flambard, Vice President, Chr. Hansen Health & Nutrition Innovation, comments on the results:
“In the support of our current probiotic products, and in the development of the next generation products, generating high quality scientific data and maintaining the best possible scientific documentation is key. We build our understanding of all our microbes using multiple in vitro and ex vivo platforms along with manufacturing characteristics and this award demonstrates the importance of such insight.”
Ida Mosbech Smith was also acknowledged for her study at the International Probiotics & Prebiotics Scientific Conference 2014, where she won the “Young Scientist Award”.
More information about the program
For more information on Chr. Hansen’s innovation programme, do not hesitate to contact Benedicte Flambard, dkbef@chr-hansen,com, +45 24 47 39 97
or visit the probiotic website: http://www.chr-hansen.com/probiotics2
Chr. Hansen is a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on more than 30,000 microbial strains – we like to refer to them as ‘good bacteria’. Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which make our products highly relevant in today’s world. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for over 140 years. We are proud that more than one billion people consume products containing our natural ingredients every day. Revenue in the 2017/18 financial year was EUR 1,097 million. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen.